![Steven Hughes](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Steven Hughes
Keine laufenden Positionen mehr
Profil
Steven G.
Hughes is Chief Development Officer at Arcturus Therapeutics, Inc. since 2020 and Chief Medical Officer at Atrium Therapeutics, Inc. Former roles include Medical Director-UK & Ireland at Biogen Idec Ltd., Chief Clinical Development Officer at Ionis Pharmaceuticals, Inc., Chief Medical Officer at VivoSim Labs, Inc. from 2018 to 2019, Chief Development Officer at Arcturus Therapeutics Holdings, Inc., and Chief Medical Officer at Avidity Biosciences, Inc. from 2022 to 2026.
Education includes a doctorate from Imperial College London and an MBA from Imperial College Business School.
Aktive Positionen von Steven Hughes
| Unternehmen | Position | Beginn |
|---|---|---|
Arcturus Therapeutics, Inc.
 Arcturus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops technology and therapeutics for rare diseases | Corporate Officer/Principal | 02.01.2020 |
Ehemalige bekannte Positionen von Steven Hughes
| Unternehmen | Position | Ende |
|---|---|---|
| AVIDITY BIOSCIENCES, INC. | Technik-/Wissenschafts-/F&E-Leiter | 27.02.2026 |
| ARCTURUS THERAPEUTICS HOLDINGS INC. | Technik-/Wissenschafts-/F&E-Leiter | 14.02.2022 |
| VIVOSIM LABS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2019 |
Biogen Idec Ltd.
 Biogen Idec Ltd. BiotechnologyHealth Technology Develops therapies for neurodegenerative, haematologic, and autoimmune disorders | Corporate Officer/Principal | - |
| IONIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Ausbildung von Steven Hughes
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
4
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Ionis Pharmaceuticals, Inc.
 Ionis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops antisense drugs | Health Technology |
VivoSim Labs, Inc.
 VivoSim Labs, Inc. BiotechnologyHealth Technology Engages in developing and commercializing functional human tissues | Health Technology |
Arcturus Therapeutics, Inc.
Arcturus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops technology and therapeutics for rare diseases | Health Technology |
Avidity Biosciences, Inc.
 Avidity Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that provides research and development, administrative & investment services | Health Technology |
Imperial College London
 Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biogen Idec Ltd.
Biogen Idec Ltd. BiotechnologyHealth Technology Develops therapies for neurodegenerative, haematologic, and autoimmune disorders | Health Technology |
Imperial College Business School
 Imperial College Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arcturus Therapeutics Holdings, Inc.
 Arcturus Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
